Previous close | 0.7850 |
Open | 0.7850 |
Bid | 0.0000 x N/A |
Ask | 0.0000 x N/A |
Day's range | 0.7850 - 0.7850 |
52-week range | 0.7850 - 18.6000 |
Volume | |
Avg. volume | 109 |
Market cap | 1.044M |
Beta (5Y monthly) | 1.46 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | 02 May 2024 - 06 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
PEARL RIVER, N.Y., April 15, 2024--Acorda Therapeutics Announces Delisting from Nasdaq
(Bloomberg) -- The junkiest corporate debt is becoming increasingly hazardous for investors amid mounting signs that a default cycle is picking up steam. Most Read from BloombergTrumpism Is Emptying ChurchesRBC Fires CFO Ahn After Probe Into Personal RelationshipThe Odds of $100 Oil Are Rising as Supply Shocks Convulse the MarketSaudis Scale Back Ambition for $1.5 Trillion Desert Project NeomIsrael Backs Out of Khan Younis to Prepare ‘Future Operations’The holding company of Thames Water Ltd. th
PEARL RIVER, N.Y., April 03, 2024--Acorda Therapeutics Announces Nasdaq Delisting Notification